MLchartDataset catalogue

EF5

Term · Oncology and biomedicine · MLC-T-ONC-002683

  1. A drug that is used to plan cancer treatment by measuring oxygen levels in tumor cells.

  2. A fluorinated derivative of the 2-nitroimidazole etanidazole. EF5 is effective in accessing oxygen levels in tumor tissue through its adduct formation to intracellular macromolecules in the absence of oxygen. Reduction of this agent is carried out by a diverse group of enzymes in the cytoplasm, microsomes and mitochondria. Tissue hypoxia detection via EF5 has been reported in several cancers, including squamous cell carcinoma of the cervix and the head and neck, and in sarcoma.

Table 1. Record
IdentifierMLC-T-ONC-002683
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-002683",
  "term": "EF5",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug that is used to plan cancer treatment by measuring oxygen levels in tumor cells.",
    "A fluorinated derivative of the 2-nitroimidazole etanidazole. EF5 is effective in accessing oxygen levels in tumor tissue through its adduct formation to intracellular macromolecules in the absence of oxygen. Reduction of this agent is carried out by a diverse group of enzymes in the cytoplasm, microsomes and mitochondria. Tissue hypoxia detection via EF5 has been reported in several cancers, including squamous cell carcinoma of the cervix and the head and neck, and in sarcoma."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ef5/"
}

Record 6,388 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.